Analytical Data
-
Gene name
ROMO1
- Application
-
Alternative Names
ROMO1；C20orf52；Reactive oxygen species modulator 1
-
Species
Mouse
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P60603
-
Expression Region
1-79aa
-
AA Sequence
MPVAVGPYGQ SQPSCFDRVK MGFVMGCAVG MAAGALFGTF SCLRIGMRGR ELMGGIGKTM MQSGGTFGTF MAIGMGIRC
-
Molecular Weight
11 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ROMO1 (Ribosome-Associated Membrane Protein 1) is a key player in the regulation of mitochondrial function and cellular metabolism. Emerging research highlights its role in oxidative stress response, where it acts as a regulator of mitochondrial dynamics and mitophagy. Dysregulation of ROMO1 has been implicated in various pathophysiological conditions, including neurodegenerative diseases, metabolic disorders, and cancer. The recombinant expression of ROMO1 allows for in-depth studies of its structure-function relationship and interactions within mitochondrial signaling pathways. Investigating ROMO1 as a recombinant protein aids in understanding its biochemical properties, contributing to the development of therapeutic strategies aimed at mitigating mitochondrial dysfunction and enhancing cellular resilience under stress. With its unique properties, ROMO1 holds promise as a potential biomarker for mitochondrial health and a target for novel treatments in diseases where mitochondrial dysfunction is a hallmark. Thus, the study of ROMO1 recombinant protein is crucial for elucidating its biological significance and therapeutic potential across various diseases.
